Recode Studios Ltd operates in personal care within Consumer Staples. Market cap ₹314.18 Cr. Profitability metrics (P/E, ROE, OPM) undisclosed — verify financial health and competitive position.
Profitability metrics n/a (P/E, ROE, OPM) — verify if company is pre-profit, loss-making, or non-transparent.
52-week range ₹174.65–₹296.4 represents 67% volatility — understand what triggered the swing.
Institutional ownership low (FII 3.41%, DII 12.25%) — verify if this reflects analyst coverage gaps or substantive concerns.
Leverage (D/E n/a) opaque — verify debt levels and financial flexibility.
Generated analysis · source review pending
Market cap ₹314.18 Cr is modest within personal care — identify expansion levers (products, geography, distribution) for scale.
52-week recovery from ₹174.65 to ₹296.4 signals investor confidence — clarify what business catalyst drove turnaround.
Personal care in Consumer Staples has inherent consumption patterns — verify if company captures sector tailwinds or lags competition.
Revenue and profitability opaque (P/E, ROE, OPM n/a) — verify growth trajectory and sustainability.
Generated analysis · source review pending
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2026 |
|---|---|
| Margins | |
| Gross margin % | 61.8% |
| EBITDA margin % | 20.7% |
| EBIT margin % | 19.5% |
| PAT margin % | 14% |
| Working capital | |
| Receivable days | — |
| Inventory days | 128 |
| Payable days | — |
| NWC days | — |
| Leverage | |
| Current ratio | 2.26 |
| Debt to EBITDA | — |
| Debt to equity | — |
| Interest coverage | 22.4 |
| Asset turnover | 2.25 |
| Return ratios | |
| Return on assets % | 31.6% |
| Return on capital employed % | 73.1% |
| Return on equity % | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Recode Studios Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Godrej Consumer Products LimitedGODREJCPGODREJCP | ₹85,949 Cr | ₹90,085 Cr | ₹16,050 Cr | ₹3,257 Cr | 20.8% | ₹2,052 Cr | 12.3% | 23.9% | 15.1% | 12 |
| Colgate Palmolive (India) LimitedCOLPALCOLPAL | ₹47,192 Cr | ₹47,192 Cr | ₹6,204 Cr | ₹1,900 Cr | 31% | ₹1,348 Cr | 22% | 106.4% | 81.6% | -188 |
| Cupid LimitedCUPIDCUPID | ₹42,022 Cr | ₹42,073 Cr | ₹453 Cr | ₹160 Cr | 32.6% | ₹137 Cr | 30.3% | 35.4% | 27.3% | 200 |
| Gillette India LimitedGILLETTEGILLETTE | ₹22,491 Cr | ₹22,491 Cr | ₹3,176 Cr | ₹961 Cr | 30.3% | ₹668 Cr | 21% | — | — | — |
| Procter & Gamble Hygiene And Health Care LimitedPGHHPGHH | ₹21,577 Cr | ₹21,577 Cr | ₹4,245 Cr | ₹1,075 Cr | 25.3% | ₹791 Cr | 18.6% | — | — | — |
| Emami LimitedEMAMILTDEMAMILTD | ₹16,266 Cr | ₹16,389 Cr | ₹3,915 Cr | ₹976 Cr | 25.5% | ₹748 Cr | 20.5% | 30.3% | 27.6% | 8 |
| Honasa Consumer LimitedHONASAHONASA | ₹13,950 Cr | ₹13,950 Cr | ₹2,553 Cr | ₹301 Cr | 9.9% | ₹249 Cr | 8.4% | 19.5% | 15.4% | -78 |
| Bajaj Consumer Care LimitedBAJAJCONBAJAJCON | ₹6,516 Cr | ₹6,516 Cr | ₹1,240 Cr | ₹264 Cr | 19% | ₹223 Cr | 16.3% | 30.5% | 25.3% | 42 |
| Recode Studios LtdRECODERECODE | ₹477 Cr | — | ₹80 Cr | ₹17 Cr | 20.7% | ₹11 Cr | 14% | — | — | — |
| Radix Industries (India) LtdRADIXINDRADIXIND | ₹193 Cr | ₹193 Cr | ₹48 Cr | ₹4 Cr | 7.6% | ₹3 Cr | 6.3% | 19.6% | 14.5% | 65 |
| H. R. Hygiene Products LtdHRHYGIENEHRHYGIENE | ₹143 Cr | — | — | — | — | — | — | — | — | — |
| Jhs Svendgaard Laboratories LimitedJHSJHS | ₹102 Cr | ₹117 Cr | ₹109 Cr | ₹3 Cr | 2.6% | ₹-2 Cr | -1.9% | -0.8% | -1.1% | 45 |
| Holder (%) | Mar 2026 |
|---|---|
| 65.02% | |
| 3.41% | |
| 12.25% | |
| Government | 0% |
| 19.32% | |
| No. of shareholders | 856 |
Promoter holding up 0 percentage points since Mar 2026.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | KIFS ENTERPRISE | Bulk | BSE | Buy | 60,800 | ₹275.16 | ₹1.67 Cr |
| 11 Aug 2026 | SHREM INVESTMENTS PRIVATE LIMITED | Bulk | BSE | Sell | 62,400 | ₹236.58 | ₹1.48 Cr |
| 10 Aug 2026 | MINT FOCUSED GROWTH FUND PCC- CELL 1 | Bulk | BSE | Sell | 1,20,800 | ₹230.50 | ₹2.78 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Documents link to external sources (exchange filings, company investor pages).
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Announcement under Regulation 30 (LODR)-Change in Management
Board Meeting Outcome for Appointment Of Secretarial Auditor For The Financial Year 2025-26
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Change in Management
Outcome Of Resolutions Passed Through Circulation By The Board Of Directors Of The Company On 24Th August, 2026
Announcement under Regulation 30 (LODR)-Change in Management
| Date | Category | Subject | Filing |
|---|---|---|---|
| 26 Aug 2026, 4:59 pm | Company Update Resignation of Company Secretary / Compliance Officer | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | |
| 25 Aug 2026, 4:53 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 25 Aug 2026, 4:50 pm | Others Outcome without intimation | Board Meeting Outcome for Appointment Of Secretarial Auditor For The Financial Year 2025-26 |
| 24 Aug 2026, 8:19 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 24 Aug 2026, 7:49 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 24 Aug 2026, 6:46 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 24 Aug 2026, 6:42 pm | Company Update General | Outcome Of Resolutions Passed Through Circulation By The Board Of Directors Of The Company On 24Th August, 2026 |
| 18 Aug 2026, 3:59 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| ₹ Cr | Mar 2026 |
|---|---|
| Revenue | 80 |
| COGS | 31 |
| Gross profit | 49 |
| 33 | |
| Operating profit (EBITDA) | 17 |
| OPM % | 20.7% |
| Depreciation | 1 |
| Interest | 1 |
| 0 | |
| Profit before tax | 15 |
| Tax | 4 |
| Tax % | 25.3% |
| PAT | 11 |
| PAT margin % | 14% |
| EPS (₹) | 13.8 |
| 1.8% |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | — |
| Reserves | — |
| Borrowings | — |
| 35 | |
| Total equity & liabilities | 35 |
| Fixed assets | 3 |
| CWIP | — |
| Investments | 0 |
| 32 | |
| Total assets | 35 |
| ₹ Cr | Mar 2026 |
|---|---|
| 4 | |
| -2 | |
| -2 | |
| Net cash flow | 1 |
| Free cash flow | 3 |
| CFO / Operating profit % | 26.2% |